EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach

Rafik Terra, Vincent Éthier, Lambert Busque, Ariane Morin-Quintal, Giovanni D'Angelo, Josée Hébert, Xuehai Wang, Guylaine Lépine, Richard LeBlanc, Julie Bergeron

Cytometry Part B: Clinical Cytometry · 2025

DOI: 10.1002/cyto.b.22213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2025. Verfasst von Rafik Terra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology and Transplantation, Department of Medicine, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Flow Cytometry, Leukemia, Myeloid, Acute, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BD Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rare acute leukemia (AL) components or subtypes such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) or early T‐cell precursor acute Lymphoblastic Leukemia (ETP‐ALL) can be difficult to detect by routine flow cytometry due to their immunophenotypes overlapping with other poorly differentiated AL. We hypothesized that using standardized EuroFlow™ Consortium approach could better diagnose such entities among cases that previously classified as acute myeloid leukemia (AML)‐M0, AML with minimal differentiation, AML with myelodysplasia‐related changes without further lineage differentiation, and AL of ambiguous lineage. In order to confirm this hypothesis and assess whether these AL subtypes such as BPDCN and ETP‐ALL had previously gone undetected, we reanalyzed 49 banked cryopreserved sample cases using standardized EuroFlow™ Consortium panels. We also performed target sequencing to capture the mutational commonalities between these AL subtypes. Reanalysis led to revised or refined diagnoses for 23 cases (47%). Of these, five diagnoses were modified, uncovering 3 ETP‐ALL and 2 typical BPDCN cases. In 12 AML cases, a variable proportion of immature plasmacytoid dendritic cell and/or monocytic component was newly identified. In one AML case, we have identified a megakaryoblastic differentiation. Finally, in five acute lymphoblastic leukemia (ALL) cases, we were able to more precisely determine the maturation stage. The application of standardized EuroFlow flow cytometry immunophenotyping improves the diagnostic accuracy of ALs and could impact treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryLeukemia, Myeloid, AcutePrecursor T-Cell Lymphoblastic Leukemia-LymphomaHumansImmunophenotypingDendritic CellsFemaleMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

EuroFlow standardized flow cytometryacute leukemiadiagnosisimmunophenotypeplasmacytoid dendritic cell

Autor:innen und Institutionen

  • Division of Hematology, Oncology and Transplantation, Department of Medicine, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.
  • Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada.
  • Division of Hematology and Oncology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Département de médecine, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont Research Center, Université de Montréal, Montreal, Quebec, Canada.
  • Département d'hémato-oncologie, Hôpital du Sacré-Coeur-de, Montréal, Quebec, Canada.

Förderung

  • BD Biosciences

Zitieren

APA

Terra, R., Éthier, V., Busque, L., Morin-Quintal, A., D'Angelo, G., Hébert, J., Wang, X., Lépine, G., LeBlanc, R., & Bergeron, J. (2025). Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22213

Vancouver

Terra R, Éthier V, Busque L, Morin-Quintal A, D'Angelo G, Hébert J, et al. Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach. Cytometry Part B: Clinical Cytometry. 2025. doi:10.1002/cyto.b.22213

BibTeX
@article{Terra2025,
  author = {Terra, Rafik and Éthier, Vincent and Busque, Lambert and Morin-Quintal, Ariane and D'Angelo, Giovanni and Hébert, Josée and Wang, Xuehai and Lépine, Guylaine and LeBlanc, Richard and Bergeron, Julie},
  title = {Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2025},
  doi = {10.1002/cyto.b.22213}
}
Kostenlos starten →